Publicacions en què col·labora amb Raffaele Strippoli (16)

2024

  1. Contribution of Autophagy to Epithelial Mesenchymal Transition Induction during Cancer Progression

    Cancers, Vol. 16, Núm. 4, pp. 807

  2. Immune checkpoints between epithelial-mesenchymal transition and autophagy: A conflicting triangle

    Cancer Letters, Vol. 585

  3. Mechanisms of mesothelial cell response to viral infections: HDAC1-3 inhibition blocks poly(I:C)-induced type I interferon response and modulates the mesenchymal/inflammatory phenotype

    Frontiers in Cellular and Infection Microbiology, Vol. 14

  4. Metal-based nanoparticles in cancer therapy: Exploring photodynamic therapy and its interplay with regulated cell death pathways

    International Journal of Pharmaceutics, Vol. 649

2023

  1. Correction to: Nanomedicine for autophagy modulation in cancer therapy: a clinical perspective (Cell & Bioscience, (2023), 13, 1, (44), 10.1186/s13578-023-00986-9)

    Cell and Bioscience

  2. Editorial: Autophagy modulation in cancer treatment utilizing nanomaterials and nanocarriers

    Frontiers in Oncology

  3. Metal-based Nanoparticles in Cancer Therapy: Exploring Photodynamic Therapy and its Interplay with Regulated Cell Death Pathways (Pre-Proof)

    International Journal of Pharmaceutics, pp. 123622

  4. Nanomedicine for autophagy modulation in cancer therapy: a clinical perspective

    Cell and Bioscience, Vol. 13, Núm. 1

2021

  1. Autophagy and the lysosomal system in cancer

    Cells, Vol. 10, Núm. 10

  2. Editorial: New Approaches to Tackle EMT and Fibrosis: From Epigenetics to Nanotechnology

    Frontiers in Pharmacology

  3. Mechanisms of Peritoneal Fibrosis: Focus on Immune Cells–Peritoneal Stroma Interactions

    Frontiers in Immunology, Vol. 12

2020

  1. Nanomaterials as inhibitors of epithelial mesenchymal transition in cancer treatment

    Cancers, Vol. 12, Núm. 1

  2. Nanomaterials for Autophagy-Related miRNA-34a Delivery in Cancer Treatment

    Frontiers in Pharmacology, Vol. 11

2019

  1. Interplay between ROS and Autophagy in Cancer and Aging: From Molecular Mechanisms to Novel Therapeutic Approaches

    Oxidative medicine and cellular longevity

  2. Sestrins as a therapeutic bridge between ros and autophagy in cancer

    Cancers, Vol. 11, Núm. 10

  3. Sestrins at the interface of ROS control and autophagy regulation in health and disease

    Oxidative Medicine and Cellular Longevity, Vol. 2019